Bipolar Disorders
Jayati T. Bist, M.A.
Clinical Research Coordinator
Massachusetts General Hospital
Boston, Massachusetts
Caylin M. Faria, B.S.
Clinical Research Coordinator II
Massachusetts General Hospital
New Bedford, Massachusetts
Hadi R. Kobaissi, B.S.
Clinical Research Coordinator
Massachusetts General Hospital
Charlestown, Massachusetts
Saee Chitale, B.A.
Clinical Research Coordinator
Massachusetts General Hospital
Somerville, Massachusetts
Antonietta Alvarez Hernandez, B.A.
Clinical Research Coordinator
Massachusetts General Hospital
Boston, Massachusetts
Yunfeng Deng, B.A.
Clinical Research Coordinator II
Massachusetts General Hospital
Cambridge, Massachusetts
Noah Stancroff, B.S.
Clinical Research Coordniator
Massachusetts General Hospital
Somerville, Massachusetts
Alexandra K. Gold, Ph.D.
Clinical Fellow in Psychology
Massachusetts General Hospital
Boston, Massachusetts
Roberta E. Tovey, Ph.D.
Director of Communications and Operations
Massachusetts General Hospital
Boston, Massachusetts
Douglas Katz, Ph.D.
Associate Director
Massachusetts General Hospital
Boston, Massachusetts
Amy Peters, Ph.D.
Assistant Professor
Massachusetts General Hospital
boston, Massachusetts
Nicha Puvanich, M.S.
Program Developer
Massachusetts General Hospital
Boston, Massachusetts
Andrew Nierenberg, M.D.
Director of Dauten Family Center For Biopolar Treatment Innovation
Massachusetts General Hospital
Boston, Massachusetts
Masoud Kamali, M.D.
Psychiatrist
Massachusetts General Hospital
Boston, Massachusetts
Louisa Sylvia, Ph.D. (she/her/hers)
Associate Professor
Massachusetts General Hospital
Boston, Massachusetts
Christina Temes, Ph.D.
Director of Psychology, Dauten Center for Bipolar Treatment Innovation
Massachusetts General Hospital
Boston, Massachusetts
Background: The Focused Integrated Team-based Treatment Program for Bipolar Disorder (FITT-BD) is an innovative treatment program that includes three core approaches: stepped care, collaborative care, and learning healthcare systems. Patients are assigned personalized skills-based interventions to meet self-identified goals. We examined the frequency with which cognitive behavioral treatment (CBT)-based interventions (i.e., cognitive restructuring, behavioral activation, mood monitoring, and psychoeducation) were assigned in FITT-BD and to whom (i.e., the baseline demographic and symptomatic characteristics).
Method: We included FITT-BD patients with complete data (N=38), or the Patient Health Questionnaire-9, assessing depressive symptoms, and a background history form. FITT-BD clinicians collaboratively develop a treatment plan with patients or identify personalized interventions for each treatment goal. Patients were female (50%), White (86.6%), non-Hispanic (97.4%) and employed (50%), with an average age of 36.7 years (SD=14.2).
Results: Over 57% of patients were assigned to cognitive restructuring, 23.7% to behavioral activation, 71.1.% to mood monitoring and 68.4% to psychoeducation interventions. Rates of assignment to CBT-based interventions did not significantly differ based on severity of depressive symptoms, but there was a trend for patients assigned to cognitive restructuring (p=0.08) to be more depressed. Patients assigned to mood monitoring tended to be older and unemployed (p=0.07 and p=0.07, respectively).
Conclusion: The most assigned CBT-based interventions were cognitive restructuring and mood monitoring in the FITT-BD program. These preliminarily data suggest that symptomatic and demographic factors could contribute to intervention selection. Future research is needed to examine these associations to better understand how to personalize treatments for individuals with bipolar disorder.